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ManganeseStore-operated Ca2+ entry (SOCE) is amajormechanism for Ca2+ inﬂux in platelets and other cells activated by
a reduction in Ca2+ concentration in the intracellular stores. SOCE has been reported to be regulated by
extracellular Ca2+, although the underlying mechanism remains unclear. Here we have examined the
involvement of plasmamembrane-located STIM1 (PM-STIM1) in the regulation of SOCE by extracellular Ca2+.
Treatment of plateletswith the SERCA inhibitor thapsigargin (TG) inducedMn2+ entry,whichwas inhibited by
extracellular Ca2+ in a concentration-dependent manner. Incubation of platelets with a speciﬁc antibody,
which recognizes the extracellular amino acid sequence 25–139 of PM-STIM1 that contains the Ca2+-binding
domain, prevented the inactivation of Ca2+ entry induced by extracellular Ca2+. TG induced translocation of
STIM1 to the plasma membrane (PM), an event that was found to be Ca2+-dependent. In addition, TG
stimulated association of PM-STIM1 with Orai1, an event that was not prevented by stabilization of the
membrane cytoskeleton using jasplakinolide. These ﬁndings suggest that PM-STIM1 is important for the
inactivation of SOCE by extracellular Ca2+, an event that is likely to be mediated by interaction with Orai1.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Cytosolic free Ca2+ concentration is a key factor in the regulation of
a number of platelet functions, including aggregation and secretion
[1,2]. In non electrically excitable cells, including platelets, store-
operated Ca2+ entry (SOCE), a mechanism regulated by the ﬁlling
state of the intracellular Ca2+ stores, is a major mechanism for Ca2+
inﬂux [3–6]. Although the event that initiates SOCE, i.e. a decrease in
the concentration of free Ca2+ in the stores, has long been
characterized, the nature of the channels, as well as the mechanisms
that regulate Ca2+ inﬂux remains unclear. In the last few years,
research concerning the nature of the channels that conduct SOCE has
been a matter of intense debate, and the reader is referred to a recent
review concerning this issue [7]. Recently, the protein Orai1 (also
named CRACM1) has been proposed to form the channel mediating
ICRAC [8–11]. Co-expression of Orai1 with the intracellular Ca2+ sensor
STIM1 has been reported to enhance SOCE [11–13], which suggests
that these proteins are sufﬁcient to mediate the process of SOCE.
STIM1 has been identiﬁed as the intraluminal Ca2+ sensor that
communicates the amount of stored Ca2+ to plasma membrane (PM)
SOC channels [14,15]. Consistent with this, mutation of the Ca2+34 927257110.
l rights reserved.binding EF-hand domain of STIM1 leads to constitutive SOC channel
activation independently of the Ca2+ content of the stores [16].
Following Ca2+ store depletion, STIM1 has been shown to associate
with Orai1 in a dynamic complex [17,18], an event that is essential for
the activation of SOCE in human platelets [19].
A number of studies have reported surface expression of STIM1
[16,20–22]. Endoplasmic reticulum (ER)-associated STIM1 (ER-STIM1)
becomes translocated toward the PM, upon store depletion, where it
might regulate the operation of SOCs. Application of speciﬁc anti-
STIM1 N-terminal antibodies to the outside of intact Jurkat T cells [21],
human platelets [22], or vascular smooth muscle cells [23] caused a
substantial attenuation of CRAC channel current and SOCE. PM-STIM1
contains its Ca2+ binding EF-hand region facing the extracellular
medium, which might be essential for sensing extracellular Ca2+
concentrations; however, as yet there are no data to support the
hypothesis that translocation of STIM1 into the PM is required for the
regulation of SOCs by the extracellular free Ca2+ concentration.
Here we have investigated the role of PM-STIM1 in the regulation
of store-dependent divalent cation entry, as well as its interaction
with the protein Orai1. The results suggest that application of
increasing concentrations of extracellular Ca2+ results in a substantial
and concentration-dependent inhibition of Mn2+ entry induced by
store depletion. This effect was prevented by extracellular application
of anti-STIM1 N-terminal antibody to intact platelets. In addition, PM-
STIM1 was found to interact with Orai1 upon store depletion, which is
consistent with a role of Orai1 in SOCE in human platelets [6, 24].
1615I. Jardín et al. / Biochimica et Biophysica Acta 1793 (2009) 1614–16222. Material and methods
2.1. Materials
Fura-2 acetoxymethyl ester (fura-2/AM) and jasplakinolide (JP)
were from Molecular Probes (Leiden, The Netherlands). Apyrase
(grade VII), aspirin, bovine serum albumin (BSA), thapsigargin (TG),
2,5-di-tert-butyl hydroquinone (TBHQ), valinomycin, dimethyl
BAPTA-AM, dithiothreitol, leupeptine, benzamidine, phenyl methyl
sulphonyl ﬂuoride (PMSF), sodium dodecyl sulphate (SDS), anti-Orai1
antibody, glutaraldehyde, paraformaldehyde and dimethyl 3,3′dithio-
bispropionimadate were from Sigma (Madrid, Spain). Anti STIM1
(25–139) antibody was from BD Transduction Laboratories (Frankin
Lakes, NJ, U.S.A.). Horseradish peroxidase-conjugated goat anti-rabbit
IgG antibody and ﬂuorescein-isothiocyanate (FITC)-conjugated don-
key anti-mouse IgG antibody were from Santa Cruz Biotechnology
(Santa Cruz, CA, U.S.A.). Horseradish peroxidase-conjugated ovine
anti-mouse IgG antibody (NA931)was fromAmersham (Buckingham-
shire, U.K.). Protein A-agarose was from Upstate Biotechnology Inc.
(Madrid, Spain). Enhanced chemiluminescence detection reagents
were from Pierce (Cheshire, U. K.). Hyperﬁlm ECLwas fromAmersham
(Arlington Heights, IL, U.S.A.). All other reagents were of analytical
grade.
2.2. Platelet preparation
Fura-2-loaded platelets were prepared as described previously
[25]. Brieﬂy, blood was obtained from drug-free healthy volunteers, in
accordance with the principles of the Declaration of Helsinki, and
mixed with one-sixth volume of acid/citrate dextrose anticoagulant
containing (in mM): 85 sodium citrate, 78 citric acid and 111 D-
glucose. Platelet-rich plasma was then prepared by centrifugation for
5 min at 700 ×g and aspirin (100 μM) and apyrase (40 μg/mL) added.
Platelet-rich plasma was incubated at 37 °C with 2 μM fura-2/AM for
45 min. For loading with dimethyl BAPTA, cells were incubated for
30 min at 37 °C with 10 μM dimethyl BAPTA-AM. Cells were then
collected by centrifugation at 350 ×g for 20 min and resuspended in
HEPES-buffered saline (HBS) containing (in mM): 145 NaCl, 10 HEPES,
10 D-glucose, 5 KCl, and 1MgSO4, pH 7.45 and supplementedwith 0.1%
w/v BSA and 40 μg/mL apyrase.
2.3. Cell viability
Cell viability was assessed using calcein and trypan blue. For calcein
loading, cells were incubated for 30 minwith 5 μM calcein-AM at 37 °C,
centrifuged and the pellet was resuspended in fresh HBS. Fluorescence
was recorded from2mLaliquotsusingaCaryEclipseSpectrophotometer
(Varian Ltd, Madrid, Spain). Samples were excited at 494 nm and the
resulting ﬂuorescence was measured at 535 nm. The results obtained
with calceinwere conﬁrmed using the trypan blue exclusion technique.
Ninety-ﬁve percent of cells were viable in our platelet preparations, at
least during the performance of the experiments.
2.4. Determination of Mn2+ entry
Mn2+ was used to monitor divalent cation entry. Mn2+ inﬂux was
monitored in 1 mL aliquots of magnetically stirred cellular suspension
(2×108 cells/mL) at 37 °C using a Cary Eclipse Spectrophotometer
(Varian Ltd, Madrid, Spain) as a quenching of fura-2 ﬂuorescence at
the isoemissive wavelength of 360 nm and presented on an arbitrary
linear scale [26]. As shown in Fig. 1F, fura-2 ﬂuorescence upon
excitation at 360 nmwas Ca2+ insensitive in our platelet preparations.
Mn2+ entry was calculated as the integral of the change in the 360 nm
ﬂuorescence for 2.5 min, taking a sample every second, after the
addition of TG, corrected by subtraction of the change in ﬂuorescence
observed in the absence of TG, and presented as arbitrary units persecond (u.a. s). To compare the rate of decay of fura-2 ﬂuorescence
when platelets were subjected to different experimental procedures
traces were ﬁtted to the equation y=Ax+B, where A is the slope and
B is the fura-2 ﬂuorescence at the initiation of the experiment.
2.5. Immunoprecipitation and Western blotting
The kinetics of the interaction between STIM1 and Orai1 were
determined in samples stimulated for various time periods before
ﬁxing using a rapid quench ﬂow system [27] (TgK Scientiﬁc Ltd.,
Salisbury, Wilts., U.K.). Brieﬂy, the cell suspension (75 μL) and an
agonist solution (75 μL) were introduced into the sample ﬂow circuit
via separate reservoirs at the top of the sample-handling unit and then
mixed after the times indicated with either 75 μL 4.5% (w/v)
paraformaldehyde or 75 μL 3% (w/v) glutaraldehyde in phosphate-
buffered saline (PBS) containing (in mM): 137 NaCl, 2.7 KCl, 5.62
Na2HPO4, 1.09 NaH2PO4, and 1.47 KH2PO4, pH 7.2 and supplemented
with 0.5% (w/v) BSA, before storing on ice for 10 min. Fixed platelets
were washed in PBS to remove the ﬁxative, incubated for 1 h with
anti-STIM1 (25–139) antibody and then washed again to remove the
antibody. Cells were then lysed by incubationwith RIPA buffer, pH 7.2,
containing 474 mM NaCl, 30 mM Tris, 3 mM EGTA, 0.3% SDS, 3%
sodium deoxycholate, 3% triton X-100, 3 mM Na3VO4, 3 mM
phenylmethylsulfonyl ﬂuoride, 150 μg/mL leupeptin and 15 mM
benzamidine. Anti-STIM1 (25–139) antibody-bound PM-STIM1 was
immunoprecipitated by addition of 25 μL of protein A-agarose
overnight at 4 °C on a rocking platform. The immunoprecipitates
were resolved by 10% SDS-PAGE and separated proteins were
electrophoretically transferred onto nitrocellulose membranes for
subsequent probing. Blots were incubated overnight with 10% (w/v)
BSA in Tris-buffered saline with 0.1% Tween 20 (TBST) to block
residual protein binding sites. Immunodetection of Orai1 and STIM1
was achieved using the anti-Orai1 antibody diluted 1:1000 in TBST for
2 h or the anti-STIM1 (25–139) antibody diluted 1:250 in TBST for 2 h.
The primary antibody was removed and blots were washed six times
for 5 min each with TBST. To detect the primary antibody, blots were
incubated for 45 minwith horseradish peroxidase-conjugated donkey
anti-rabbit IgG antibody or horseradish peroxidase-conjugated ovine
anti-mouse IgG antibody, respectively, diluted 1:10,000 in TBST and
then exposed to enhanced chemiluminescence reagents for 4 min.
Blots were then exposed to photographic ﬁlms. The density of bands
on the ﬁlm was measured using a scanning densitometry.
2.6. Immunoﬂuorescence
The amount of PM-STIM1 was determined in samples collected at
several times before ﬁxing using a rapid quench ﬂow system (TgK
Scientiﬁc Ltd., Salisbury, Wilts., U.K.). Brieﬂy, the cell suspension
(75 μL) and an agonist solution (75 μL) were introduced into the
sample ﬂow circuit via separate reservoirs at the top of the sample-
handling unit and then mixed after the times indicated with 75 μL
15 mg/mL (w/v) dimethyl 3,3′dithiobispropionimadate [28] in PBS
before storing for 10min. Fixed plateletswerewashed in PBS to remove
the ﬁxative and incubated for 2 h with 1 μg/mL anti-STIM1 (25–139)
antibody. The platelets were then collected by centrifugation and
washed twice in PBS. To detect the primary antibody, samples were
incubated with 0.02 μg/mL FITC-conjugated donkey anti-rabbit IgG
antibody for 1 h andwashed twice in PBS. Fluorescencewas measured
using a microplate reader Inﬁnite M200 (Tecan, Männedorf, Switzer-
land). Samples were excited at 496 nm and emission was at 600 nm.
2.7. Statistical analysis
Analysis of statistical signiﬁcance was performed using Student's
unpaired t-test. For multiple comparisons, one-way analysis of
variance combined with the Dunnett's tests was used.
Fig.1. Concentration-dependent effect of extracellular Ca2+ on TG-evokedMn2+ entry. (A–D) Human platelets were loadedwith fura-2 and resuspended in HBS. Valinomycin (3 μM)
was added 5 min before the onset of the experiment. At the time of experiment CaCl2 (0–3 mM), as indicated, and 500 μMMn2+ were added. Fura-2 ﬂuorescence was measured at
the isoemissive excitation wavelength of 360 nm. Platelets were either left untreated (trace a) or stimulated with TG (200 nM; trace b). Traces are representative of six separate
experiments. (E) Data indicate the percentage of Mn2+ entry in the presence of different concentrations of extracellular Ca2+ relative to their control ([Ca2+]o=0mM; 100 μM EGTA
added). Mn2+ entry was determined as described in the Materials and methods section. Values are means±SEM; signiﬁcance values indicate differences compared with TG-treated
cells in the absence of extracellular Ca2+. ⁎⁎⁎pb0.001. (F) Fura-2-loaded human platelets were treated with valinomycin (3 μM) 5min before the onset of the experiment. At the time
of experiment CaCl2 (1mM) and 500 μMMn2+were added. Fura-2 ﬂuorescencewasmeasured at the isoemissive excitationwavelength of 360 nm. Platelets were stimulatedwith TG
(200 nM) and 4 min later 20 μM TBHQ was added. Traces are representative of ﬁve separate experiments. (G) Fura-2-loaded platelets were suspended in HBS. Valinomycin (3 μM)
was added 5 min before the onset of the experiment. At the time of experiment CaCl2 (3 mM) was added and then cells were stimulated with 200 nM TG. Fura-2 ﬂuorescence was
measured at 340 nm and the isoemissive excitation wavelength of 360 nm. Traces are representative of four separate platelet preparations.
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3.1. Effect of increasing concentrations of extracellular Ca2+ on
TG-evoked Mn2+ entry in human platelets
We have investigated the effect of increasing concentrations of
extracellular Ca2+ on store-operated divalent cation entry by
determination of Mn2+ inﬂux since Mn2+ can be used as a surrogate
for Ca2+ given its quenching effect on fura-2 ﬂuorescence [29,30]. The
use of Mn2+ avoids complications arising from the stimulation of the
PM Ca2+-ATPase (PMCA) [31], since Mn2+ is transported with lower
afﬁnity than Ca2+ by PMCA [32], and this ion is a known inhibitor of
the Na+/Ca2+ exchanger [33]. The experiments were performed in thepresence of the K+ ionophore valinomycin (3 μM), which stabilizes
the platelet membrane potential close to the K+ equilibrium potential
[34], avoiding interferences in Mn2+ entry due to different membrane
depolarization expected in cells exposed to distinct extracellular Ca2+
concentrations. As shown in Fig. 1A, treatment of platelets with
200 nM TG, a speciﬁc inhibitor of the Ca2+-ATPase of internal stores
(SERCA), in a Ca2+-free medium and in the presence of 500 μM
external Mn2+, resulted in a sustained quenching of fura-2 ﬂuores-
cence (trace b; the slope was −1.27±0.09) compared with non-
treated cells (trace a; slope=−0.67±0.05). The integral of the
change in the 360 nm ﬂuorescence for 2.5min after the addition of TG,
corrected by subtraction of the change in ﬂuorescence observed in the
absence of TG, was 60.34±3.15 a.u. s. The slope of the decrease in
Fig. 2. Effect of extracellular Ba2+ on TG-evokedMn2+ entry. (A and B) Human platelets
were loaded with fura-2 and resuspended in HBS. Valinomycin (3 μM)was added 5 min
before the onset of the experiment. At the time of experiment BaCl2 (0 or 3 mM), as
indicated, and 500 μM Mn2+ were added. Fura-2 ﬂuorescence was measured at an
excitation wavelength of 360 nm, the isoemissive wavelength. Platelets were either left
untreated (trace a) or stimulated with TG (200 nM; trace b). Traces are representative
of six separate experiments. (C) Histograms indicating the percentage of Mn2+ entry in
the presence of different concentrations of extracellular Ba2+ relative to their control
([Ba2+]o=0mM; 100 μMEGTA added). Mn2+ entry was determined as described in the
Materials and methods section. Values are means±SEM.
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the presence of TG, was signiﬁcantly reduced in the presence of
increasing concentrations of extracellular Ca2+ (−1.15±0.06,−0.81±
0.07 and −0.63±0.03 at 0.3, 1 and 3 mM extracellular Ca2+,
respectively; Fig. 1B–D). Similarly, TG-evoked Mn2+ entry was
signiﬁcantly reduced by extracellular Ca2+ in a concentration-
dependent manner (the integral of the change in the fura-2
ﬂuorescence for 2.5 min after the addition of TG, corrected by
subtraction of the change in ﬂuorescence observed in the absence of
TG, was 36.25±2.33, 22.07±2.01 and 20.67±1.96 a.u. s at 0.3, 1 and
3 mM extracellular Ca2+, respectively; Fig. 1B–E).
Human platelets express two SERCA isoforms, SERCA2b is present
in the dense tubular system and is sensitive to low concentrations of
TG [35–37], while SERCA3 isoforms are present in acidic organelles
[37], show low sensitivity to TG [38,39] and, in contrast to SERCA2b,
are sensitive to 2,5-di-(t-butyl)-1,4-hydroquinone (TBHQ) [40]. As
shown in Fig.1F, at the concentration of 200 nM, TGwas able to inhibit
SERCA2b, which is very sensitive to TG, and SERCA3, since TBHQ was
unable to induce further Mn2+ entry. As shown in Fig. 1G, the fura-2
ﬂuorescence at 360 nm was insensitive to changes in cytosolic Ca2+
concentration.
We have further investigated whether the inhibitory effect of
extracellular Ca2+ on store-operated Mn2+ entry might be mediated
by interference of Ca2+ inﬂuxwithMn2+ entry, as the driving force for
Ca2+ entry increases with the extracellular concentration. To explore
this possibility we substitute extracellular Ca2+ by Ba2+, a divalent
cation that enters the cell through the store-operated divalent cation
channels [41]. As shown in Fig. 2, the slope of the decrease in fura-2
ﬂuorescence both in cells stimulated with TG or in the non-treated
cells was found to be similar in the presence of 3 mM Ba2+ and in a
Ba2+-free medium. In addition, TG-evoked Mn2+ entry was similar
in the absence or presence of extracellular Ba2+ (the integral of the
change in the fura-2 ﬂuorescence for 2.5 min after the addition of TG,
corrected by subtraction of the change in ﬂuorescence observed in
the absence of TG, was 47.34±6.84 and 44.69±2.50 a.u. s at 0 or
3 mM extracellular Ba2+, respectively; Fig. 2). These ﬁndings indicate
that the inhibition of Mn2+ by extracellular Ca2+ is unlikely
attributed to physical interference with Mn2+ inﬂux.
3.2. Incubation with anti-STIM1 (25–139) antibody prevents the
inhibitory effect of extracellular Ca2+ on TG-evoked Mn2+ entry
Since PM-STIM1 contains its Ca2+ binding EF-hand region facing
the extracellular medium, we have investigated its possible role in the
regulation ofMn2+ entry by extracellular Ca2+ by using a speciﬁc anti-
STIM1 (25–139) antibody that recognizes the amino acid sequence
25–139, which includes the Ca2+-binding EF-hand region [42]. As
shown in Fig. 3, the fura-2 ﬂuorescence quenching after addition of
Mn2+ in the absence and presence of TG was not modiﬁed by
extracellular Ca2+ when platelets were incubated for 60 min with
1 μg/mL anti-STIM1 (25–139) antibody. The quenching slope was
−0.48±0.04, −0.49±0.07, −0.47±0.05 and −0.43±0.04 in the
absence of TG and −0.75±0.06, −0.79±0.09, −0.75±0.09 and
−0.66±0.07 in the presence of TG at 0, 0.3, 1 and 3 mM extracellular
Ca2+, respectively (Fig. 3A–D), and the integral of the change in the
360 nm ﬂuorescence for 2.5 min after the addition of TG, corrected by
subtraction of the change in ﬂuorescence observed in the absence of
TG, was 34.94±7.57, 35.52±8.71, 35.09±7.53 and 34.7±6.65 a.u. s
at 0, 0.3, 1 and 3 mM extracellular Ca2+ (Fig. 3A–E).
The effect of incubation with anti-STIM1 (25–139) antibody was
found to be concentration-dependent, with a detectable effect at
0.1 μg/mL with a quenching slope of −0.62±0.09 and a maximal
effect at 2 μg/mL anti-STIM1 antibody with quenching slope of
−0.96±0.12 (Fig. 4C and D). As shown in Fig. 4A and B, incubation
for 60 min with the same concentrations of an anti-mouse IgG, of the
same nature as the anti-STIM1 antibody, did not modify Mn2+ entryin resting or TG-treated cells, thus suggesting that the effect observed
was speciﬁc of the anti-STIM1 antibody.
3.3. Effect of TG on the surface expression of STIM1
Recent studies have reported that STIM1 might be located in the
membrane of the Ca2+ stores and at the PM [16,20–22]. STIM1 has
been suggested tomigrate to the PMupon depletion of the Ca2+ stores
where the N-terminus faces the extracellular medium, as detected by
immunoﬂuorescence and immunoelectronmicroscopy [14,16]. On the
basis of the N-terminal location of the epitope recognized by the anti-
STIM1 (25–139) antibody, we have performed a series of immuno-
ﬂuorescence experiments to conﬁrm this hypothesis and further
investigate the role of extra and intracellular Ca2+ ions in this process.
Human platelets were stimulated with 200 nM TG and the latencies of
TG-evoked surface expression of STIM1 were determined by means of
a quench ﬂow system and immunoﬂuorescence. As shown in Fig. 5,
incubation of ﬁxed, nonpermeabilized resting platelets in suspension
with 1 μg/mL anti-STIM1 (25–139) antibody followed by detection
using an FITC-conjugated secondary antibody revealed the presence of
Fig. 3. Inhibition of the effect of extracellular Ca2+ on TG-evokedMn2+ entry by incubationwith anti-STIM1 (25–139) antibody. (A–D) Human platelets were incubated with 1 μg/mL
anti-STIM1 (25–139) antibody for 60 min at 37 °C, loaded with fura-2, centrifuged at 350 ×g for 20 min, and resuspended in HBS. Valinomycin (3 μM) was added 5 min before the
onset of the experiment. At the time of experiment CaCl2 (0–3 mM), as indicated, and 500 μMMn2+ were added. For experiments in a Ca2+-free medium 100 μM EGTAwas added.
Fura-2 ﬂuorescence was measured at an excitation wavelength of 360 nm, the isoemissive wavelength. Platelets were either left untreated (trace a) or stimulated with TG (200 nM;
trace b). Traces are representative of six separate experiments. (E) Data indicating the percentage of Mn2+ entry in the presence of different concentrations of extracellular Ca2+
relative to their control ([Ca2+]o=0 mM; 100 μM EGTA added). Mn2+ entry was determined as described in the Materials and methods section. Values are means±SEM.
1618 I. Jardín et al. / Biochimica et Biophysica Acta 1793 (2009) 1614–1622STIM1 proteins in the cellular surface. The ﬂuorescence detected was
unlikely attributed to nonspeciﬁc binding of the secondary antibody
since samples incubated with the secondary antibody alone reported
less than 20% of the ﬂuorescence observed in the presence of the anti-
STIM1 (25–139) antibody (data not shown). Data presented in Fig. 5
were corrected by subtraction of the ﬂuorescence due to the
secondary antibody alone. In the presence of 1 mM extracellular Ca2+,
platelet stimulation with TG enhanced surface expression of STIM1
by 44% and 28% at 10 or 60 s of stimulation with TG (Fig. 5). In the
absence of extracellular Ca2+ (100 μM EGTA was added to the
medium), the effect of TG was impaired at least for 60 s, thus
suggesting that extracellular Ca2+ is a requisite for TG-evoked
translocation of STIM1 to the PM (Fig. 5; pb0.05; n=6). Similar
results were observed when cells were loaded with dimethyl BAPTA
and suspended in a Ca2+-free medium (Fig. 5; pb0.05; n=6), which
further supports the role of intra and extracellular Ca2+ in TG-
induced surface expression of STIM1.
3.4. Association between plasma membrane STIM1 and the membrane
protein Orai1
A number of studies have demonstrated association between STIM1
and Orai1 in different cell types [11,17,43–45], including humanplatelets [19]; however, whether the interaction involves plasma
membrane-located STIM1 or is speciﬁc for STIM1 located in the ER
remains unclear. Therefore, we have tested for the association between
PM-STIM1 and Orai1 by looking for co-immunoprecipitation. Platelets
heavily loaded with the Ca2+ chelator dimethyl BAPTA were used for
this study to investigate whether this response requires rises in
cytosolic free Ca2+ concentration. Cells were rapidly mixed with
200 nM TG and incubated at 37 °C for various time periods (0.8–60 s)
before mixing with paraformaldehyde (1.5% in PBS). Paralleled
experiments were performed using the ﬁxer glutaraldehyde, which
reported similar results (data not shown). Fixed cells werewashed and
incubated with anti-STIM1 (25–139) antibody for 2 further hours,
washed, and lysed. Immunoprecipitation was performed overnight in
the presence of agarose beads without further addition of antibodies
and subsequent SDS-PAGE andWestern blotting were conducted using
control platelets and platelets stimulated with 200 nM TG for various
periods of time. We found that store depletion by TG increased the
associationbetweenPM-STIM1andOrai1 in a time-dependentmanner,
reaching amaximum after 10 s of stimulationwith TG by 36% and then
decreased, reaching a plateau that was maintained for at least 60 s
(Fig. 6 bottom panel and histogram; pb0.05; n=6). Western blotting
of the samemembraneswith anti-STIM1(25–139) antibodyconﬁrmed
a similar content of this protein in all lanes (Fig. 6, bottom panel).
Fig. 4. Concentration-dependent effect of the anti-STIM1 antibody on the effect of extracellular Ca2+ on TG-evoked Mn2+ entry. Human platelets were incubated with various
concentrations (0.1–2 μg/mL) of mouse IgG (A and B) or anti-STIM1 (25–139) antibody (C and D) for 60 min at 37 °C, loaded with fura-2, centrifuged at 350 ×g for 20 min, and
resuspended in HBS. Valinomycin (3 μM) was added 5 min before the onset of the experiment. At the time of experiment CaCl2 (0–1 mM), as indicated, and 500 μM Mn2+ were
added. For experiments in a Ca2+-free medium 100 μM EGTA was added. Fura-2 ﬂuorescence was measured at an excitation wavelength of 360 nm, the isoemissive wavelength.
Platelets were either treated with vehicle (DMSO; control) or stimulated with TG (200 nM), as indicated. Traces are representative of six separate experiments.
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with Orai1 might be mediated by homotypic association with ER-
STIM1 or by an independent mechanism by testing the effect of
jasplakinolide (JP), a cell-permeant peptide isolated from Jaspis
johnstoni, which elongates and organizes actin ﬁlaments exclusively
at the cell periphery and we have previously used to stabilize the
membrane actin cytoskeleton in platelets and to prevent the
interaction between ER and PM [46]. Treatment of dimethyl
BAPTA-loaded human platelets with 10 μM JP for 30 min at 37 °C
did not signiﬁcantly modify the interaction between PM-STIM1 and
Orai1 in resting cells and did not signiﬁcantly reduce TG-evokedFig. 5. Time-course of TG-induced surface expression of STIM1. Platelets were either
suspended in a medium containing 1 mM Ca2+, or in a Ca2+-free medium (100 μM
EGTA was added) or were loaded with dimethyl BAPTA and suspended in a Ca2+-free
medium, as indicated. Cells were rapidly mixed with 200 nM TG and incubated at 37 °C
for various time periods (10 or 60 s) before mixing with dimethyl 3,3′dithiobispropio-
nimadate (5 mg/mL in PBS). Cells were then incubated with 1 μg/mL anti-STIM1 (25–
139) antibody for 2 h followed by incubationwith FITC-conjugated anti-mouse IgG for a
further 1 h. Histograms indicate the immunoﬂuorescence values under different
experimental conditions. Values are means±SEM of six independent experiments.
⁎⁎⁎pb0.001 compared to control (cells not stimulated with TG).interaction between both proteins, as detected by co-immunopreci-
pitation (Fig. 7; n=6), thus suggesting that this interaction occurs
independently of ER-STIM1.
4. Discussion
It has been reported that SOCE can be regulated by extracellular
Ca2+ [47]. Recent studies have provided evidence supporting the
translocation of STIM1 from the Ca2+ stores to the PM, where the EF-
hand is located extracellularly [16,20–22], which raises the possibility
that PM-STIM1 acts as an extracellular Ca2+ sensor. We have
explored the effect of extracellular Ca2+ on SOCE indirectly by
testing Mn2+ inﬂux in order to avoid interferences due to the
different concentrations of extracellular Ca2+ or the activation of
different plasma membrane handling pumps and exchangers. We
have shown that extracellular Ca2+ efﬁciently prevents Mn2+ entry
induced by TG. This process cannot be attributed either to physical
interaction of Ca2+ with Mn2+ at the level of their entry, since Ca2+
substitution for Ba2+ eliminated the inhibitory effect on Mn2+ inﬂux,
or to variations in the membrane potential induced when large or
small amounts of Ca2+ (depending on the extracellular Ca2+
concentration) enter the cells, since the membrane potential was
stabilized near the K+ equilibrium potential by valinomycin [34]. The
inhibition of TG-induced Mn2+ entry mediated by Ca2+ was
prevented when platelets were incubated with an antibody that
speciﬁcally recognizes the N-terminal sequence of STIM1 (anti-STIM1
(25–139) antibody), containing the EF-hand Ca2+ binding domain,
extracellularly. The effect of incubation with the anti-STIM1 antibody
was concentration-dependent and unlikely mediated by nonspeciﬁc
binding of the antibody, since incubation with a mouse IgG was
without effect. Previous studies have reported that this antibody is
unable to enter intact platelets [22], thus suggesting that the EF-hand
domain of STIM1 facing the extracellular medium is important for the
regulation of SOCE. Despite the fact that incubation with the anti-
STIM1 (25–139) antibody signiﬁcantly reduces the attenuation of TG-
evoked Mn2+ entry induced by extracellular Ca2+, we cannot rule out
the possibility that intracellular mechanisms, activated by rises in
Fig. 6. Time-course of TG-induced association of plasma membrane STIM1 and Orai1 in
human platelets. Dimethyl BAPTA-loaded human platelets were suspended in a Ca2+-
free medium (100 μM EGTA added) and then rapidly mixed with 200 nM TG and
incubated at 37 °C for various time periods (0.8–60 s) before mixing with
paraformaldehyde (1.5% in PBS). Cells were then incubated with 1 μg/mL anti-STIM1
(25–139) antibody for 2 h, washed twice in PBS and lysed. Whole cell lysates were
incubated overnight with 25 μg/mL agarose beads and immunoprecipitates were
subjected to 10% SDS-PAGE and subsequent Western blotting with a speciﬁc anti-Orai1
antibody. Membranes were reprobed with the anti-STIM1 (25–139) antibody for
protein loading control. The panel shows results from one experiment representative of
5 others. Molecular masses indicated on the right were determined using molecular-
mass markers run in the same gel. Histograms represent the quantiﬁcation of plasma
membrane STIM1 (PM-STIM1)-Orai1 association in resting (control) and TG-treated
cells. Results are presented as arbitrary optical density units and expressed as means±
SEM. ⁎pb0.05 and ⁎⁎⁎pb0.001 compared to control (cells not stimulated with TG).
Fig. 7. TG-induced association of plasma membrane STIM1 and Orai1 is not sensitive to
jasplakinolide. Dimethyl BAPTA-loaded human platelets were preincubated in the
presence of 10 μM JP for 30 min or the vehicle (control) and suspended in a Ca2+-free
medium (100 μM EGTA added). Cells were either untreated (resting) or rapidly mixed
with 200 nM TG and incubated at 37 °C for 10 s before mixing with paraformaldehyde
(1.5% in PBS), as indicated. Cells were then incubatedwith 1 μg/mL anti-STIM1 (25–139)
antibody for 2 h, washed twice in PBS and lysed. Whole cell lysates were incubated
overnight with 25 μg/mL agarose beads and immunoprecipitates were subjected to 10%
SDS-PAGE and subsequent Western blotting with a speciﬁc anti-Orai1 antibody.
Membranes were reprobed with the anti-STIM1 (25–139) antibody for protein loading
control. The panel shows results from one experiment representative of 5 others.
Molecular masses indicated on the right were determined using molecular-mass
markers run in the same gel. Histograms represent the quantiﬁcation of plasma
membrane STIM1 (PM-STIM1)-Orai1 association in resting and TG-treated cells
incubated in the absence or presence of JP. Results are presented as arbitrary optical
density units and expressed as means±SEM.
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SOCE, as previously described to calmodulin [48,49].
Our results suggest that treatment of humanplatelets with 200 nM
TG inhibits the activity of both SERCA isoforms described in platelets,
SERCA2b and 3, since TBHQ was without effect on Mn2+ entry after
treatment with TG (see Fig. 1F). These isoforms are located in separate
Ca2+ stores that are involved in the activation of two distinct
pathways for SOCE in these cells [50]. We have found that both
SERCA isoforms, SERCA3 [51] and SERCA2b (Redondo PC, personal
communication) associate with protein complexes, including STIM1,
in human platelets. Therefore, both SOCE pathways might be
regulated by extracellular Ca2+ through PM-STIM1, although this
issue deserves further studies.
We have further investigated the possible interaction of PM-STIM1
with other proteins involved in SOCE in platelets, such as Orai1 [19].
We have found that Ca2+ store depletion using TG resulted in a time-
dependent translocation of STIM1 to the PM, an effect that is regulated
by Ca2+. In cells loaded with dimethyl BAPTA, and in the absence of
extracellular Ca2+, we have found time-dependent interaction of PM-
STIM1 with Orai1, which reached a maximum effect after 10 s of
treatment with TG, which strongly suggests that this mechanism is
activated by store depletion and not by rises in cytosolic Ca2+
concentration. Although speculative, the reduction in the interaction
between Orai1 and PM-STIM1 after 10 s might be attributed to the
association of Orai1 with other SOCE proteins, such as TRPCs, which
associate with Orai1 in human platelets upon stimulation with TGreaching a maximum after 30 s of stimulation [19,52]. The association
of PM-STIM1 with Orai1 might regulate the formation of heteromeric
complexes that have been proposed to be the base of SOCE/ICRAC
channels [43,53,54].
Interaction of ER-STIM1 and PM-STIM1 has been previously
demonstrated [14,55]; therefore, despite having tested that in our
conditions the anti-STIM1 (25–139) antibody cannot enter intact
platelets, we could not rule out the possibility that PM-STIM1
immunoprecipitates also include ER-STIM1, which might be respon-
sible for the associationwith Orai1. This issue was explored by the use
of JP, which prevents the interaction between ER and PM by stabilizing
the membrane cytoskeleton in human platelets [46]. The results
obtained in the presence of JP strongly suggest that the interaction
between PM-STIM1 and Orai1 does not involve ER-STIM1.
In summary, we have shown that extracellular Ca2+ regulates
store-operated cation entry in human platelets. This process might
compensate the amount of Ca2+ entry through SOCE when platelets
are exposed to relatively different extracellular Ca2+ concentrations
due to hypo and hypercalcemia; therefore, protecting platelet function
from changes in extracellular Ca2+ concentration. This mechanism
might also serve to protect the cells from an excessive Ca2+ inﬂux
when platelets are exposed to high extracellular Ca2+ concentration,
1621I. Jardín et al. / Biochimica et Biophysica Acta 1793 (2009) 1614–1622which might lead to the activation of apoptotic mechanisms [56]. The
reported mechanism might involve PM-associated STIM1, which
exposes the EF-hand Ca2+-binding motif to the extracellular medium,
thus acting as an extracellular Ca2+ sensor. Platelet treatment with TG
induces Ca2+-dependent translocation of STIM1 to the PM. Modula-
tion of store-operated cation entry might be mediated by interaction
between PM-STIM1 and the PM protein Orai1, whichmight be a major
event in the regulation of SOCE in these cells. Our results are
compatible with a dual role of STIM1 in the regulation of SOCE in
human platelets. ER-associated STIM1 might act as an intraluminal
Ca2+ sensor involved in the initiation of SOCE through its interaction
with the PM proteins [19,22], while PM-STIM1, whose Ca2+ sensor
domain faces the extracellular medium, might be essential for the
regulation of SOC channel function by interaction with Orai1.
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